Sun Pharma appoints Richard Ascroft as North America CEO to lead U.S. and Canada operations, including new drug launches and ...

The new CEO Richard Ascroft brings more than 30 years of industry experience, including senior roles at Takeda ...

Incyte’s Hervé Hoppenot is hanging up his hat after spending more than a decade building the company into the ...

Sun Pharmaceutical Industries Ltd. closed 13.89% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

Sun Pharmaceutical Industries Ltd. closed 14.84% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

India's top drugmakers are reportedly sitting on their highest cash reserves in at least five years, up over 120% from FY20 ...

In FY25 alone, the cash pile increased by over Rs 10,200 crore, underscoring a decisive shift in the capital allocation ...

Important Announcement. Dear readers, We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we ...

They further pointed out that Sun Pharma’s application to register 'PruEase' was made only in 2022, while RSPL had been using and marketing 'Pro-Ease' since 2012. The appellant also alleged that Sun ...

Sun Pharmaceutical Industries has appointed Kirti Ganorkar as its new managing director, effective September 1. Dilip Shanghvi, the current managing director, will remain with the company as executive ...